300030.SZ
Improve Medical Instruments Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.95
−2.62%Oct 27, 2026, 08:09 UTC
Guangzhou Improve Medical Instruments Co., Ltd. received approval to renew its medical device production license, valid from December 27, 2026, through December 26, 2031.
Source:Sep 18, 2026, 09:52 UTC
Yangpu Medical's wholly owned subsidiary Guangzhou Yangpu Medical Devices received a Class II medical device license from Health Canada for its single-use anti-needlestick intravenous blood collection needle.
Source:Aug 14, 2026, 10:44 UTC
Yangpu Medical announced its 2026 first-half results: net profit attributable to shareholders was 30.8149 million yuan, up 101.85% year-on-year, with revenue of 215 million yuan, down 6.87%.
Source:Jul 2, 2026, 10:45 UTC
Yangpu Medical's wholly-owned subsidiary Yangpu Medical (Hunan) obtained a Medical Device Production License from the Hunan Provincial Drug Administration, covering changes in production scope and renewal of the license period.
Source: